Phil Robinson
Professor
Infection and Immunity
Murdoch Childrens Research Institute
Australia
Biography
Associate Professor Philip Robinson has been involved in paediatric respiratory research for more than 25 years including many innovative multi-centre drug trials as well as individually designed and led projects involving aspects of lung disease including cystic fibrosis and Primary ciliary dyskinesia (PCD). He has completed an MD thesis by research into aspects of malabsorption in cystic fibrosis and later a PhD in the effect of smoking in-utero on lung growth and development. A/Prof Robinson is a member of the first and only research team in the southern hemisphere to successfully use hyper polarised helium as an imaging tool for assessing lung disease. In the past four years his team has been involved in 10 multicentre drug trials in cystic fibrosis including trials of the new mutational specific drug, Ivacaftor.
Research Interest
Respiratory Medicine and Pediatric
Publications
-
Robinson P, Schechter MS, Sly PD, Winfield K, Smith J, Brennan S, Shinkai M, Henke MO, Rubin BK. Clarithromycin therapy for patients with cystic fibrosis: a randomized controlled trial. Pediatric pulmonology. 2012 Jun 1;47(6):551-7.
-
Loeve M, Van Hal PT, Robinson P, Williams TJ, Nossent G, Tiddens H. The spectrum of structural abnormalities on CT scans from CF patients with severe advanced lung disease. Thorax. 2009 Jun 18.
-
Kidd TJ, Ramsay KA, Hu H, Bye PT, Elkins MR, Grimwood K, Harbour C, Marks GB, Nissen MD, Robinson PJ, Rose BR. Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients. Journal of clinical microbiology. 2009 May 1;47(5):1503-9.
